Autonomix Medical, Inc. Common Stock Cash Flow Conversion Efficiency
Autonomix Medical, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has a cash flow conversion efficiency ratio of -1.121x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.54 Million) by net assets ($3.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Autonomix Medical, Inc. Common Stock (2022–2026)
Cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2026. This chart illustrates how Autonomix Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Autonomix Medical, Inc. Common Stock (AMIX) share price today for real-time trading data and today's change.
Autonomix Medical, Inc. Common Stock Cash Flow Conversion Ratio Explained
Autonomix Medical, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Autonomix Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see AMIX market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Haoxin Holdings Limited Class A Ordinary Shares
NASDAQ:HXHX
|
-0.029x |
|
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
|
-0.012x |
|
SRx Health Solutions Inc.
NYSE MKT:SRXH
|
18.676x |
|
OFAL
NASDAQ:OFAL
|
-0.413x |
|
KARELIAN DIA.R. EO-00025
F:KJY1
|
N/A |
|
Morarjee Textiles Limited
NSE:MORARJEE
|
-0.006x |
|
Univa Foods Limited
NSE:UNIVAFOODS
|
-0.001x |
|
Sienna Resources Inc
V:SIE
|
-0.071x |
Annual Cash Flow Conversion Efficiency for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2026. Review Autonomix Medical, Inc. Common Stock financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $5.89 Million | $-12.28 Million | -2.083x | -104.33% |
| 2025-03-31 | $8.10 Million | $-8.26 Million | -1.020x | -16.99% |
| 2024-03-31 | $7.63 Million | $-6.65 Million | -0.872x | +69.73% |
| 2023-03-31 | $644.00K | $-1.85 Million | -2.880x | -1356.83% |
| 2022-03-31 | $1.96 Million | $-387.31K | -0.198x | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more